Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

8
Axon Enterprise (AAXN) Q2 Earnings Top, Revenues Improve Y/Y

2018-08-08 zacks - 2
Axon Enterprise, Inc.’s (AAXN - Free Report) second-quarter 2018 adjusted earnings came in at 18 cents per share surpassing the Zacks Consensus Estimate of 9 cents by 100%. The bottom line also improved 100% on a year-over-year basis.
ELY ICFI FBHS JCI AAXN

0
Banks ready US$10bn plus debt deal for Johnson Controls buyout

2018-08-01 reuters
LONDON (LPC) - Banks are working on debt financing of more than $10 billion to finance the buyout of Johnson Controls International Plc’s (JCI.N) power solutions business, banking sources said on Wednesday.
JCI

4
Johnson Controls International Plc (JCI) Q3 2018 Results - Earnings Call Transcript

2018-07-31 seekingalpha
Welcome to Johnson Controls Third Quarter 2018 Earnings Call. Your lines have been placed on listen-only until the question-and-answer session. This conference is being recorded. If you have any objections, please disconnect at this time.
WFC WFCNP JCI

8
Johnson Controls (JCI) Q3 Earnings & Revenues Beat Estimates

2018-07-31 zacks
Johnson Controls International plc (JCI - Free Report) reported adjusted earnings per share of 81 cents in third-quarter fiscal 2018, beating the Zacks Consensus Estimate of 80 cents. Moreover, earnings increased 14% from 50 cents recorded in third-quarter fiscal 2017.
FOXF CWH OSK GPN JCI

0
Johnson Controls International plc 2018 Q3 - Results - Earnings Call Slides

2018-07-31 seekingalpha
The following slide deck was published by Johnson Controls International plc in conjunction with their 2018 Q3 earnings call.
JCI

3
FCE.A Stock Price - Forest City Realty Trust Inc. Cl A Stock Quote (U.S.: NYSE) - MarketWatch

2018-07-31 marketwatch
Brookfield to pay $25.35 for each Forest City Realty share, a 10% premium to Monday's closing price
BAMGF FCEA AMGN TCO PGEJF FCE.B FCE.A PGSVY BDRLF JCI BAMKF BAM

0
JCI / Johnson Controls International plc 8-K (Current Report)

2018-07-31 sec.gov
Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549
JCI

5
Johnson Controls (JCI) Q3 Earnings: What's in the Cards?

2018-07-25 zacks
Johnson Controls International plc (JCI - Free Report) is set to report third-quarter fiscal 2018 results before the opening bell on Jul 31.
FOXF LMT AXL BP BP.A BP.B VC BP BPAQF JCI NEE

0
JCI / Johnson Controls International plc S-8

2018-07-20 sec.gov
Document As filed with the Securities and Exchange Commission on July 20, 2018
JCI

83
Jane's June Dividend Increases And Income - Retirement Accounts

2018-07-19 seekingalpha - 2
This is the fourth month I have officially tracked dividend income (in an article) for Jane's Traditional and Roth IRA Accounts. Her dividend income totaled $1,319.70.
GIS CAT WBA ENB OPRF JCI HSY ABBV MMM POL MO DUKH GD TRV MAIN CMI ENB RY BNS JNJ TROW VZ WPC ABBV MSFT ADM PFE PM PFBC SCL IRET CTL OXLCM OXLCO TD ETN OXLCN BNS CM MSCA INTC TD IBM RY TNTTF LYB MSB O DUK SNX OXLC IRM MSCA.CL EMRAF ORI PPL CBL

14
7 Alternative Internet of Things Stocks to Buy

2018-07-17 investorplace - 1
As an investment sector, the Internet of Things, or IoT, is a no-brainer. Increasingly, our consumer devices no longer have a specific function or operation; rather, they’re part of an integrated, digital ecosystem that responds to variable requests. This movement will only increase in volume and engagement, but picking the right IoT stock can be a challenge.
ADT FIT HON MU GRMN AAPL ADI EMR JCI INTC NTGR

58
Allegion: Unlocking Growth In A Cyclical Market

2018-07-12 seekingalpha
"It's far better to buy a wonderful company at a fair price than a fair company at a wonderful price."
ADT FBHS ALLE MCO BSWQY SPB AMZN SWK HON IR JNJ DRRKF SPB CSCO JCI MMM

1
Fortune Brands Teams Up With Renoworks to Boost Offerings

2018-07-11 zacks
Therma-Tru Corp — a leading entry door brand of Fortune Brands Home & Security, Inc. (FBHS - Free Report) — recently teamed up with Renoworks Software Inc. to integrate its Design Your Door tool with the Renoworks home visualization platform. With this integration, homeowners will be able to view the latest library of Therma-Tru doors in their homes with participating Renoworks dealers.
ROWKF FBHS ATKR WBT JCI RW

93
July 2018 Stock Considerations

2018-07-02 seekingalpha
Here we are with another installment of my "stock considerations" for the upcoming month. With the first week of trading upon us in July, it is time, once again, to lay out a plan for my potential stock pick(s) for the month. As many of you already know, I make sure to purchase at least one stock every single month, no matter where we are in a business or macroeconomic cycle. The goal of every long-term dividend growth investor is to remain consistent with their buys and try not to attempt to time the market and wait for the "best" possible time to invest.
SOJA HCN PM GIS HCP LTC SBRA WELL CAH ED JCI SBRAP VTR SO GE GEC D KMB PEP KHC GNE SBUX CLX

Related Articles

REPH: Recro Pharma Analysis and Research Report

10h - Asif

Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...

ACHN: Achillion Pharmaceuticals Analysis and Research Report

11h - Asif

Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...

BTE: Baytex Energy Trust Analysis and Research Report

11h - Asif

General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...

CUSIP: G51502105